HAVN Life Sciences Inc. HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVN

Rang in Aktien #38603
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Aktienkurs
$0.02201811
Zuletzt synchronisiert: 2024-07-23
Marktkapitalisierung
$847.02K
Veränderung (1 Tag)
-0.22%
Veränderung (1 Jahr)
21,918.11%
Land
CA
Handel HAVN Life Sciences Inc. (HAVN)

Kategorie

Healthcare
Dividendenrendite-Verlauf für HAVN Life Sciences Inc. (HAVN)
Dividendenrendite (TTM) von HAVN Life Sciences Inc. (Aktienkürzel: HAVN) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für HAVN Life Sciences Inc. (HAVN) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL